Bioteque Corporation (4107.TWO)
TWD 120.0
(-1.23%)
TWD 120.0
(-1.23%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 580.17 Million TWD | -7.54% |
| 2022 | 627.49 Million TWD | 16.18% |
| 2021 | 540.09 Million TWD | -10.46% |
| 2020 | 603.21 Million TWD | 1.46% |
| 2019 | 594.5 Million TWD | 21.53% |
| 2018 | 489.19 Million TWD | 14.25% |
| 2017 | 428.17 Million TWD | -2.4% |
| 2016 | 438.69 Million TWD | 19.14% |
| 2015 | 368.22 Million TWD | 23.43% |
| 2014 | 298.31 Million TWD | 26.16% |
| 2013 | 236.46 Million TWD | 52.63% |
| 2012 | 154.92 Million TWD | 46.41% |
| 2011 | 105.82 Million TWD | -39.4% |
| 2010 | 174.61 Million TWD | 12.37% |
| 2009 | 155.39 Million TWD | 82.18% |
| 2008 | 85.3 Million TWD | 68.67% |
| 2007 | 50.57 Million TWD | 1.25% |
| 2006 | 49.95 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 151.56 Million TWD | 7.88% |
| 2024 Q1 | 140.49 Million TWD | -15.76% |
| 2023 Q1 | 126.89 Million TWD | -11.7% |
| 2023 Q2 | 137.18 Million TWD | 8.11% |
| 2023 FY | 580.17 Million TWD | -7.54% |
| 2023 Q4 | 166.78 Million TWD | -7.78% |
| 2023 Q3 | 180.85 Million TWD | 31.83% |
| 2022 Q2 | 161.64 Million TWD | 6.46% |
| 2022 Q4 | 143.7 Million TWD | -15.63% |
| 2022 Q1 | 151.82 Million TWD | 0.69% |
| 2022 FY | 627.49 Million TWD | 16.18% |
| 2022 Q3 | 170.32 Million TWD | 5.37% |
| 2021 Q4 | 150.78 Million TWD | 24.07% |
| 2021 Q1 | 152.46 Million TWD | -13.41% |
| 2021 FY | 540.09 Million TWD | -10.46% |
| 2021 Q2 | 122.95 Million TWD | -19.35% |
| 2021 Q3 | 121.52 Million TWD | -1.16% |
| 2020 FY | 603.21 Million TWD | 1.46% |
| 2020 Q1 | 134.51 Million TWD | -6.95% |
| 2020 Q4 | 176.06 Million TWD | 14.4% |
| 2020 Q3 | 153.9 Million TWD | 8.08% |
| 2020 Q2 | 142.39 Million TWD | 5.86% |
| 2019 FY | 594.5 Million TWD | 21.53% |
| 2019 Q2 | 156.06 Million TWD | 14.8% |
| 2019 Q1 | 135.94 Million TWD | 4.56% |
| 2019 Q4 | 144.56 Million TWD | 0.45% |
| 2019 Q3 | 143.91 Million TWD | -7.78% |
| 2018 FY | 489.19 Million TWD | 14.25% |
| 2018 Q3 | 119.03 Million TWD | -6.08% |
| 2018 Q4 | 130.02 Million TWD | 9.23% |
| 2018 Q1 | 113.39 Million TWD | -6.34% |
| 2018 Q2 | 126.74 Million TWD | 11.77% |
| 2017 Q4 | 121.07 Million TWD | 9.16% |
| 2017 Q1 | 93.1 Million TWD | -0.92% |
| 2017 Q3 | 110.91 Million TWD | 7.6% |
| 2017 FY | 428.17 Million TWD | -2.4% |
| 2017 Q2 | 103.07 Million TWD | 10.71% |
| 2016 Q2 | 118.98 Million TWD | 4.75% |
| 2016 Q3 | 112.13 Million TWD | -5.76% |
| 2016 Q4 | 93.97 Million TWD | -16.2% |
| 2016 FY | 438.69 Million TWD | 19.14% |
| 2016 Q1 | 113.59 Million TWD | 21.23% |
| 2015 FY | 368.22 Million TWD | 23.43% |
| 2015 Q1 | 88.52 Million TWD | 14.23% |
| 2015 Q4 | 93.7 Million TWD | 9.41% |
| 2015 Q2 | 100.36 Million TWD | 13.38% |
| 2015 Q3 | 85.63 Million TWD | -14.67% |
| 2014 Q4 | 77.49 Million TWD | -3.08% |
| 2014 FY | 298.31 Million TWD | 26.16% |
| 2014 Q3 | 79.95 Million TWD | 4.31% |
| 2014 Q2 | 76.64 Million TWD | 19.36% |
| 2014 Q1 | 64.21 Million TWD | 1.43% |
| 2013 Q4 | 63.31 Million TWD | -0.94% |
| 2013 FY | 236.46 Million TWD | 52.63% |
| 2013 Q1 | 48.4 Million TWD | 28.98% |
| 2013 Q2 | 60.83 Million TWD | 25.68% |
| 2013 Q3 | 63.91 Million TWD | 5.07% |
| 2012 Q2 | 36.21 Million TWD | 4.27% |
| 2012 Q1 | 34.73 Million TWD | 16.33% |
| 2012 Q3 | 46.59 Million TWD | 28.64% |
| 2012 FY | 154.92 Million TWD | 46.41% |
| 2012 Q4 | 37.52 Million TWD | -19.46% |
| 2011 Q2 | 20.92 Million TWD | -16.86% |
| 2011 Q1 | 25.16 Million TWD | -28.99% |
| 2011 FY | 105.82 Million TWD | -39.4% |
| 2011 Q3 | 29.87 Million TWD | 42.8% |
| 2011 Q4 | 29.85 Million TWD | -0.05% |
| 2010 Q4 | 35.43 Million TWD | -28.21% |
| 2010 Q3 | 49.36 Million TWD | 8.26% |
| 2010 Q2 | 45.59 Million TWD | 3.13% |
| 2010 Q1 | 44.21 Million TWD | 0.0% |
| 2010 FY | 174.61 Million TWD | 12.37% |
| 2009 FY | 155.39 Million TWD | 82.18% |
| 2008 FY | 85.3 Million TWD | 68.67% |
| 2007 FY | 50.57 Million TWD | 1.25% |
| 2006 FY | 49.95 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | 605.69 Million TWD | 4.214% |
| Chi Sheng Pharma & Biotech Co., Ltd | 61.21 Million TWD | -847.783% |
| Sunder Biomedical Tech. Co., Ltd. | -28.05 Million TWD | 2168.216% |
| BenQ Medical Technology Corporation | 365.43 Million TWD | -58.762% |
| Pacific Hospital Supply Co., Ltd | 498.01 Million TWD | -16.498% |
| Unicon Optical Co., Ltd. | -117.03 Million TWD | 595.733% |
| Formosa Optical Technology Co.,Ltd. | 328.02 Million TWD | -76.869% |
| Medeon Biodesign, Inc. | -839.56 Million TWD | 169.104% |
| Concord Medical Co., Ltd. | 54.91 Million TWD | -956.498% |
| Crystalvue Medical Corporation | 117.67 Million TWD | -393.02% |
| Perfect Medical Industry Co., Ltd. | 58.37 Million TWD | -893.929% |
| ICARES Medicus, Inc. | 118.64 Million TWD | -389.01% |
| Lagis Enterprise Co., Ltd. | 77.1 Million TWD | -652.488% |
| Amed Co., Ltd. | 123.28 Million TWD | -370.597% |